Fesik; Stephen W.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Fesik; Stephen W..The latest application filed is for "wdr5-myc inhibitors".
Company Profile
9.22.29
- Fesik; Stephen W. - Nashville TN
- Fesik; Stephen W. - Gurnee IL
Patent Activity
| Patent | Date |
|---|---|
| Wdr5-myc Inhibitors App 20220289673 - Tansey; William P. ; et al. | 2022-09-15 |
| Wdr5 Inhibitors And Modulators App 20220242849 - Lee; Taekyu ; et al. | 2022-08-04 |
| Quinazoline compounds as modulators of Ras signaling Grant 11,318,137 - Waterson , et al. May 3, 2 | 2022-05-03 |
| Substituted indole Mcl-1 inhibitors Grant 11,208,415 - Lee , et al. December 28, 2 | 2021-12-28 |
| Substituted Indole Mcl-1 Inhibitors App 20210283138 - Lee; Taekyu ; et al. | 2021-09-16 |
| Substituted indole Mcl-1 inhibitors Grant 10,954,193 - Lee , et al. March 23, 2 | 2021-03-23 |
| Substituted benzofuran, benzothiophene and indole Mcl-1 inhibitors Grant 10,844,032 - Lee , et al. November 24, 2 | 2020-11-24 |
| WDR5 inhibitors and modulators Grant 10,844,044 - Alvarado , et al. November 24, 2 | 2020-11-24 |
| WDR5-MLL1 inhibitors and modulators Grant 10,807,959 - Gogliotti , et al. October 20, 2 | 2020-10-20 |
| Quinazoline Compounds As Modulators Of Ras Signaling App 20200253974 - Kind Code | 2020-08-13 |
| Substituted Indole Mcl-1 Inhibitors App 20200140447 - Lee; Taekyu ; et al. | 2020-05-07 |
| Wdr5 Inhibitors And Modulators App 20200102288 - Alvarado; Joseph R. ; et al. | 2020-04-02 |
| Wdr5-mll1 Inhibitors And Modulators App 20200055824 - Gogliotti; Rocco D. ; et al. | 2020-02-20 |
| Substituted indole Mcl-1 inhibitors Grant 10,533,010 - Lee , et al. Ja | 2020-01-14 |
| WDR5 inhibitors and modulators Grant 10,501,466 - Fesik , et al. Dec | 2019-12-10 |
| Wdr5 Inhibitors And Modulators App 20190084988 - Fesik; Stephen W. ; et al. | 2019-03-21 |
| WDR5 inhibitors and modulators Grant 10,160,763 - Fesik , et al. Dec | 2018-12-25 |
| Substituted Benzofuran, Benzothiophene And Indole Mcl-1 Inhibitors App 20180312485 - Lee; Taekyu ; et al. | 2018-11-01 |
| Substituted benzofuran, benzothiophene and indole MCL-1 inhibitors Grant 10,093,640 - Lee , et al. October 9, 2 | 2018-10-09 |
| Substituted Indole Mcl-1 Inhibitors App 20180258039 - Lee; Taekyu ; et al. | 2018-09-13 |
| Substituted indole Mcl-1 inhibitors Grant 10,005,728 - Lee , et al. June 26, 2 | 2018-06-26 |
| Tricyclic indole Mcl-1 inhibitors and uses thereof Grant 9,949,965 - Lee , et al. April 24, 2 | 2018-04-24 |
| Wdr5 Inhibitors And Modulators App 20180086767 - Fesik; Stephen W. ; et al. | 2018-03-29 |
| Substituted Indole Mcl-1 Inhibitors App 20170174689 - Lee; Taekyu ; et al. | 2017-06-22 |
| Substituted Indole Mcl-1 Inhibitors App 20160214934 - Lee; Taekyu ; et al. | 2016-07-28 |
| Tricyclic Indole Mcl-1 Inhibitors And Uses Thereof App 20160106731 - Lee; Taekyu ; et al. | 2016-04-21 |
| Substituted Benzofuran, Benzothiophene And Indole Mcl-1 Inhibitors App 20150336925 - Lee; Taekyu ; et al. | 2015-11-26 |
| Methods For Assessing The Delivery Of Exogenous Agents App 20100251392 - Shen; Yu ; et al. | 2010-09-30 |
| N-acylsulfonamide apoptosis promoters Grant 7,754,886 - Augeri , et al. July 13, 2 | 2010-07-13 |
| Methods for Assessing the Delivery of Exogenous Agents App 20100115635 - Shen; Yu ; et al. | 2010-05-06 |
| N-acylsulfonamide Apoptosis Promoters App 20090137585 - Augeri; David J. ; et al. | 2009-05-28 |
| N-acylsulfonamide apoptosis promoters Grant 7,504,512 - Augeri , et al. March 17, 2 | 2009-03-17 |
| Mutant Bcl-2 proteins and uses thereof Grant 7,226,992 - Fesik , et al. June 5, 2 | 2007-06-05 |
| Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor App 20060293229 - Fesik; Stephen W. ; et al. | 2006-12-28 |
| Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals App 20060031945 - Shen; Yu ; et al. | 2006-02-09 |
| Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor Grant 6,897,337 - Fesik , et al. May 24, 2 | 2005-05-24 |
| N-acylsulfonamide apoptosis promoters App 20040192681 - Augeri, David J. ; et al. | 2004-09-30 |
| Method of killing cancer cells App 20040180844 - Fesik, Stephen W. ; et al. | 2004-09-16 |
| Method of killing cancer cells App 20040180848 - Fesik, Stephen W. ; et al. | 2004-09-16 |
| Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor App 20040086938 - Fesik, Stephen W. ; et al. | 2004-05-06 |
| N-acylsulfonamide apoptosis promoters Grant 6,720,338 - Augeri , et al. April 13, 2 | 2004-04-13 |
| Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor App 20030124673 - Fesik, Stephen W. ; et al. | 2003-07-03 |
| N-Acylsulfonamide apoptosis promoters App 20020086887 - Augeri, David J. ; et al. | 2002-07-04 |
| N-acylsulfonamide apoptosis promoters App 20020055631 - Augeri, David J. ; et al. | 2002-05-09 |
| Use of 13C nuclear magnetic resonance to detect binding to target molecules App 20020037529 - Fesik, Stephen W. ; et al. | 2002-03-28 |
| Use Of 13c Nuclear Magnetic Resonance To Detect Binding To Target Molecules App 20010004528 - FESIK, STEPHEN W. ; et al. | 2001-06-21 |
| Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules Grant 6,043,024 - Fesik , et al. March 28, 2 | 2000-03-28 |
| Use of nuclear magnetic resonance to design ligands to target biomolecules Grant 5,989,827 - Fesik , et al. November 23, 1 | 1999-11-23 |
| Use of nuclear magnetic resonance to design ligands to target biomolecules Grant 5,891,643 - Fesik , et al. April 6, 1 | 1999-04-06 |
| Use of nuclear magnetic resonance to identify ligands to target biomolecules Grant 5,804,390 - Fesik , et al. September 8, 1 | 1998-09-08 |
| Use of nuclear magnetic resonance to identify ligands to target biomolecules Grant 5,698,401 - Fesik , et al. December 16, 1 | 1997-12-16 |
Company Registrations
| SEC | 0001434744 | Fesik Stephen W. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 